HMS
MYGN icon

Hanseatic Management Services’s Myriad Genetics MYGN Stock Holding History

Hanseatic Management Services’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-72
Closed -$2K – 442
2018
Q1 		$2K Hold
72
– – ﹤0.01% 339
2017
Q4 		$2K Sell
72
-20
-22% -$675 ﹤0.01% 331
2017
Q3 		$3K Buy
+92
New +$2.62K ﹤0.01% 303

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hanseatic Management Services's MYGN Position: Q2 2018 in Review

Hanseatic Management Services sold out of Myriad Genetics (MYGN) in Q2 2018, closing a stake of 72 shares — an estimated $2K sold.

Hanseatic Management Services first reported a position in MYGN in Q3 2017 and held it in 3 quarters. The position peaked at $3K in Q3 2017. 258 funds tracked by Wall St. Rank hold MYGN as of Q2 2018.

  • Hanseatic Management Services reported no remaining Myriad Genetics position as of Q2 2018 after selling out during the quarter.
  • Hanseatic Management Services sold 72 Myriad Genetics shares in Q2 2018, an estimated $2K.
  • Hanseatic Management Services first reported a position in Myriad Genetics in Q3 2017 and held it in 3 quarters.
  • Hanseatic Management Services's Myriad Genetics position peaked at $3K in Q3 2017.
  • 258 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2018.

Based on Hanseatic Management Services's 13F filing for Q2 2018, filed 14 Aug 2018.